These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1783455)
1. Improved on-line thoracic duct drainage for lymphocytapheresis. Sato T; Koga N; Nagano T; Ohteki H; Masuda T; Agishi T Int J Artif Organs; 1991 Dec; 14(12):800-4. PubMed ID: 1783455 [TBL] [Abstract][Full Text] [Related]
2. [Lymphocytapheresis and lymphosorption as the methods of pathogenetic therapy of nonspecific ulcerative colitis]. Ganichkin AM; Iaitskiĭ NA; Dudka VV; Vasil'ev SV; Grigorian VV; Aĭvazian IA Vestn Khir Im I I Grek; 1991 Jan; 146(1):28-31. PubMed ID: 1650992 [TBL] [Abstract][Full Text] [Related]
4. The effect of thoracic duct drainage on lymphocyte dynamics and clinical symptoms in patients with rheumatoid arthritis. Ueo T; Tanaka S; Tominaga Y; Ogawa H; Sakurami T Arthritis Rheum; 1979 Dec; 22(12):1405-12. PubMed ID: 518724 [TBL] [Abstract][Full Text] [Related]
5. Extracorporeal irradiation of thoracic duct lymph as immunosuppressive treatment in rheumatoid arthritis. Edgren J; Klockars M; Weber T; Wangel A; Linström B; Stenstrand K; Pettersson T; Riska H; Kajander A; Wegelius O Scand J Rheumatol; 1976; 5(2):108-12. PubMed ID: 1084574 [TBL] [Abstract][Full Text] [Related]
6. Cell separating property and clinical effect of lymphocytapheresis with leukocyte removal filter. Akizawa T; Kinugasa E; Koshikawa S; Nishimura T; Kuroda H Prog Clin Biol Res; 1990; 337():23-5. PubMed ID: 2352982 [No Abstract] [Full Text] [Related]
7. Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis. Kondoh T; Hidaka Y; Katoh H; Inoue N; Saito S Artif Organs; 1991 Jun; 15(3):180-8. PubMed ID: 1867528 [TBL] [Abstract][Full Text] [Related]
9. Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage. Machleder HI; Paulus H Surgery; 1978 Jul; 84(1):157-65. PubMed ID: 307281 [No Abstract] [Full Text] [Related]
10. The effects of repeated leukapheresis in patients with severe refractory rheumatoid arthritis. Wilder RL; Yarboro CH; Decker JL Prog Clin Biol Res; 1982; 106():49-59. PubMed ID: 6757953 [No Abstract] [Full Text] [Related]
11. Lymphocytapheresis in the treatment of rheumatoid arthritis: clinical and immunological studies. Indiveri F; Rogna S; Viglione D; Pierri I; Scudeletti M; Grifoni V Int J Artif Organs; 1985 May; 8(3):147-54. PubMed ID: 3875567 [TBL] [Abstract][Full Text] [Related]
12. [Extracorporeal immunotherapy in rheumatoid polyarthritis]. Boloşiu HD; Duţu A Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(5):393-400. PubMed ID: 6113657 [No Abstract] [Full Text] [Related]
13. Efficient harvest of in vivo IL-2-activated CD3+ lymphocytes for adoptive immunotherapy by selective leukapheresis (lymphocytapheresis). Masucci G; Svensson A; Hansson M; Hansson J; Nakazawa T; Salazar F; Petersson M; Kiessling R J Hematother; 1997 Jun; 6(3):253-60. PubMed ID: 9234180 [TBL] [Abstract][Full Text] [Related]
14. Characterization of recirculating lymphocytes in rheumatoid arthritis patients: selective deficiency of natural killer cells in thoracic duct lymph. Fox RI; Fong S; Tsoukas C; Vaughan JH J Immunol; 1984 Jun; 132(6):2883-7. PubMed ID: 6609962 [TBL] [Abstract][Full Text] [Related]
15. Human T-lymphotropic virus type I associated myelopathy treated effectively with lymphocytapheresis using a leukocyte removal filter. Oishi M; Mochizuki Y; Hara M; Uryu H; Osaka S; Maejima M; Sawada S; Takasu T Intern Med; 1995 Dec; 34(12):1215-9. PubMed ID: 8929654 [TBL] [Abstract][Full Text] [Related]